Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: Filgrastim|DRUG: Docetaxel|DRUG: Doxorubicin|PROCEDURE: Surgery
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: National Cancer Institute (NCI)|Aventis Pharmaceuticals